Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Annual Review of Pharmacology and Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.PHARMTOX.40.1.581PMID 10836148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depression and the Severity of Substance Abuse

  2000cited by this paper
• Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved.

  1999cited by this paper
• Carcinogens in the diet vs. overnutrition. Individual dietary habits, malnutrition, and genetic susceptibility modify carcinogenic potency and cancer risk.

  1999cited by this paper
• Repairing the Genome's Spelling Mistakes

  1999cited by this paper
• Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides.

  1999cited by this paper
• Formation of HNK-1 Determinants and the Glycosaminoglycan Tetrasaccharide Linkage Region by UDP-GlcUA:Galactose β1,3-Glucuronosyltransferases*

  1999cited by this paper
• Intermittent complete androgen blockade in metastatic prostate cancer.

  1999cited by this paper
• Global cancer statistics

  1999cited by this paper
• Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase.

  1999cited by this paper
• Chinese Hamster Ovary Cell Mutants Defective in Glycosaminoglycan Assembly and Glucuronosyltransferase I*

  1999cited by this paper
• Cloning and Expression of a Novel Galactoside β1,3-Glucuronyltransferase Involved in the Biosynthesis of HNK-1 Epitope*

  1999cited by this paper
• Retigabine N-glucuronidation and its potential role in enterohepatic circulation.

  1999cited by this paper
• Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.

  1999cited by this paper
• Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate.

  1999cited by this paper
• UDP-glucuronosyltransferase activity in human liver and colon.

  1999cited by this paper
• The role of interindividual variation in human carcinogenesis.

  1999cited by this paper
• Characterization of UDP-glucuronosyltransferases active on steroid hormones.

  1999cited by this paper
• Drug glucuronidation by human renal UDP-glucuronosyltransferases.

  1998cited by this paper
• Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.

  1998cited by this paper
• Expression of the UDP-glucuronosyltransferase 1A Locus in Human Colon

  1998cited by this paper
• Intermittent Complete Androgen Blockade in Metastatic Prostate Cancer

  1998cited by this paper
• Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.

  1998cited by this paper
• Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line.

  1998cited by this paper
• Biochemical and molecular aspects of genetic disorders of bilirubin metabolism.

  1998cited by this paper
• Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.

  1998cited by this paper
• The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268).

  1998cited by this paper
• Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7.

  1998cited by this paper
• Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11.

  1998cited by this paper
• Antiandrogens as Monotherapy for Prostate Cancer

  1998cited by this paper
• Determinants of UDP glucuronosyltransferase membrane association and residency in the endoplasmic reticulum.

  1998cited by this paper
• UDP-glucuronosyltransferases in human intestinal mucosa.

  1998cited by this paper
• Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.

  1998cited by this paper
• Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins.

  1998cited by this paper
• Species differences in N-glucuronidation.

  1998cited by this paper
• Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8.

  1998cited by this paper
• Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes.

  1998cited by this paper
• Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon.

  1998cited by this paper
• Cloning of the human UGT1 gene complex in yeast artificial chromosomes: novel aspects of gene structure and subchromosomal mapping to 2q37.

  1997cited by this paper
• The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid.

  1997cited by this paper
• Heterologous expression of human drug-metabolizing enzymes.

  1997cited by this paper
• Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.

  1997cited by this paper
• The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.

  1997cited by this paper
• The regio- and stereo-selectivity of C19 and C21 hydroxysteroid glucuronidation by UGT2B7 and UGT2B11.

  1997cited by this paper
• Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications.

  1997cited by this paper
• Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.

  1997cited by this paper
• Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis.

  1997cited by this paper
• Structure of the human UGT2B4 gene encoding a bile acid UDP-glucuronosyltransferase

  1997cited by this paper
• Expression and Functional Domains of Rabbit Liver UDP-glucuronosyltransferase 2B16 and 2B13*

  1997cited by this paper
• Baculovirus-directed expression of rabbit UDP-glucuronosyltransferases in Spodoptera frugiperda cells.

  1997cited by this paper
• Chromosomal Localization, Structure, and Regulation of the UGT2B17 Gene, Encoding a C19 Steroid Metabolizing Enzyme

  1997cited by this paper
• Human UGT2B7 catalyzes morphine glucuronidation.

  1997cited by this paper
• Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer.

  1997cited by this paper
• Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.

  1996cited by this paper
• Steroid UDP glucuronosyltransferases: characterization and regulation.

  1996cited by this paper
• Isolation and Characterization of a Novel cDNA Encoding a Human UDP-Glucuronosyltransferase Active on C19 Steroids*

  1996cited by this paper
• Genetic diseases of bilirubin metabolism: the inherited unconjugated hyperbilirubinemias.

  1996cited by this paper
• cDNA cloning and characterization of the human UDP glucuronosyltransferase, UGT1A3.

  1996cited by this paper
• Risk factors for ifosfamide nephrotoxicity in children.

  1996cited by this paper
• Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis.

  1996cited by this paper
• Mutational Analysis of the Carboxy-Terminal Region of UDP-Glucuronosyltransferase 2B1

  1996cited by this paper
• Identification of bilirubin UDP-GTs in the human alimentary tract in accordance with the gut as a putative metabolic organ.

  1996cited by this paper
• Anti‐cytochrome P450 autoantibodies in drug‐induced disease

  1996cited by this paper
• The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1.

  1996cited by this paper
• Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome

  1996cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP‐glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler‐Najjar type IIs

  1996cited by this paper
• Autoimmunity in hepatitis C and D virus infection

  1996cited by this paper
• Duodenal biopsies for xenobiotic metabolism studies in human individuals

  1996cited by this paper
• Formation of mono- and diglucuronides and other glycosides of benzo(a)pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex.

  1995cited by this paper
• Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation.

  1995cited by this paper
• Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphateglucuronosyltransferase

  1995cited by this paper
• Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.

  1995cited by this paper
• The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

  1995cited by this paper
• Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.

  1995cited by this paper
• Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides.

  1995cited by this paper
• Molecular biology of bilirubin metabolism.

  1995cited by this paper
• Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.

  1995cited by this paper
• Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line.

  1995cited by this paper
• Altered Coding for a Strictly Conserved Di-glycine in the Major Bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar Type I Patient *

  1995cited by this paper
• Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man.

  1994cited by this paper
• Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.

  1994cited by this paper
• Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.

  1994cited by this paper
• N-glucuronidation reactions. III. Regioselectivity of N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyltransferases stably expressed in V79 cells.

  1994cited by this paper
• A New Type of Defect in the Gene for Bilirubin Uridine 5 '-Diphosphate-Glucuronosyltransferase in a Patient with Crigler-Najjar Syndrome Type I

  1994cited by this paper
• Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferase of the UGT1 gene complex.

  1994cited by this paper
• Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.

  1994cited by this paper
• Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.

  1994cited by this paper
• Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13.

  1994cited by this paper
• Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.

  1994cited by this paper
• Bilirubin metabolism and the hereditary hyperbilirubinemias.

  1994cited by this paper
• Genetic and biochemical analysis of alternative RNA splicing.

  1994cited by this paper
• A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.

  1993cited by this paper
• A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase.

  1993cited by this paper
• Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol.

  1993cited by this paper
• cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.

  1993cited by this paper
• Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms.

  1993cited by this paper
• Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.

  1993cited by this paper
• Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.

  1993cited by this paper
• Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.

  1993cited by this paper
• Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.

  1993cited by this paper

• UDP-Glucuronosyl transferase mediated drug-drug interactions: An Industry perspective on recommended in vitro studies.

  2026cites this paper
• The critical need to implement pharmacogenomics in public health services: Mexico in the global picture

  2026cites this paper
• ADME profile of phencyclidine (PCP) analogues: emerging dissociative hallucinogens 3-MeO-PCP (CAS: 72242-03-6) and 4-MeO-PCP (CAS: 2201-35-6)-a multi-in silico approach for comprehensive prediction of absorption, distribution, metabolism and excretion relevant to clinical and forensic toxicology.

  2026cites this paper
• Biosynthesis of silver and gold nanoparticles using cyanobacteria, their pharmaceutical and industrial applications

  2025cites this paper
• Hepatic Biotransformation in Climbing Perch Anabas testudineus Exposed to Polystyrene Microplastics at Environmentally Relevant Concentrations

  2025cites this paper
• Tandem mass tag (TMT) proteomic analysis of rohu intestine against Edwardsiella tarda

  2025cites this paper
• Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action

  2025cites this paper
• A Synthetic Lectin for Glucuronate

  2025cites this paper
• Insight into the structure, oligomerization, and the role in drug resistance of human UDP-glucuronosyltransferases

  2025cites this paper
• In-vitro metabolites characterization of 1,3-diphenylguanidine and 1,3-di-o-tolylguanidine by high-resolution mass spectrometry and urinary profiling

  2025cites this paper
• Decoding the Impact of Genetic Polymorphisms in Xenobiotic Metabolizing Enzymes and Ovarian Cancer: A Comprehensive Review

  2025cites this paper
• Important role of OATP in the liver disposition of ezetimibe and its consequent glucuronidation metabolite.

  2025cites this paper
• Deconjugation enzymes - pitfalls, contamination risks, and practical insights from human biomonitoring of bisphenols, phthalates, and oxidative stress markers.

  2025cites this paper
• Dolutegravir metabolism: impact of genetic variations on uridine diphosphate glucuronosyltransferase subfamilies

  2025cites this paper
• Occurrence and characteristics of bisphenols, triclosan, and their conjugated metabolites in human urine.

  2025cites this paper
• Electrochemical analysis and in silico molecular docking with tropomyosin-related kinase B reveals electron shuttles-mediated neuroprotective potential of mandarin orange pu-erh tea extracts

  2025cites this paper
• Heme and CO metabolism by the canonical human heme oxygenases.

  2025cites this paper
• Glucuronolactone Restores the Intestinal Barrier and Redox Balance Partly Through the Nrf2/Akt/FOXO1 Pathway to Alleviate Weaning Stress-Induced Intestinal Dysfunction in Piglets

  2025cites this paper
• Identification of isomeric glucuronides by electronic excitation dissociation tandem mass spectrometry

  2025cites this paper
• The Potential Therapeutic Effects of MEAI in the Treatment of Alcohol Use Disorder

  2025cites this paper
• Oviduct fluid metabolic regulation of embryonic genome methylation

  2025cites this paper
• Beyond Ornithine Metabolism in Gyrate Atrophy: Tissue-Specific Proteomic Insights into Neonatal and Adult OAT Deficiency

  2025cites this paper
• Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronosyltransferase (UGT) 1A1.

  2024cites this paper
• Drug Metabolizing Enzymes: An Exclusive Guide into Latest Research in Pharmaco-genetic Dynamics in Arab Countries.

  2024cites this paper
• Pesticide exposure and oxidative stress generation are linked to poor prognosis outcomes in breast cancer women carrying the allelic variant rs7438135 in the UGT2B7 gene

  2024cites this paper
• Fluorogenic Probes for Functional Imaging of Endoplasmic Reticulum‐Resident Proteins: from Molecular Engineering to Biomedical Applications

  2024cites this paper
• Deciphering Drug Resistance: Investigating the Emerging Role of Hyaluronan Metabolism and Signaling and Tumor Extracellular Matrix in Cancer Chemotherapy

  2024cites this paper
• Triclosan administration to humanized UDP-glucuronosyltransferase 1 neonatal mice induces UGT1A1 through a dependence on PPARα and ATF4

  2024cites this paper
• A multi-technique based analytical platform for characterization and identification of a newly emerged steroid 6β-chlorotestosterone and its in-vivo epimeric metabolites

  2024cites this paper
• Hepatic Metabolic Enzyme Activity with Endogenous Substances-current Status, Challenges and Limitations.

  2024cites this paper
• Dysregulated Glucuronidation of Bilirubin Exacerbates Liver Inflammation and Fibrosis in Schistosomiasis Japonica through the NF-κB Signaling Pathway

  2024cites this paper
• From hazard to risk prioritization: a case study to predict drug-induced cholestasis using physiologically based kinetic modeling

  2024cites this paper
• Synthesis and protective effect of 7-O-thiazole Oroxylin A derivative against diabetic nephropathy in streptozotocin-induced diabetes in Wistar rats

  2024cites this paper
• UGT2B10 is the Major UDP-Glucuronosyltransferase 2B Isoform Involved in the Metabolism of Lamotrigine and is Implicated in the Drug-Drug Interaction with Valproic Acid

  2024cites this paper
• Breast Milk Jaundice

  2024cites this paper
• A high-affinity fluorescent probe for human uridine-disphosphate glucuronosyltransferase 1A9 function monitoring under environmental pollutant exposure.

  2024cites this paper
• Neuroprotective Roles of the Biliverdin Reductase-A/Bilirubin Axis in the Brain

  2024cites this paper
• Vancomycin relieves tacrolimus-induced hyperglycemia by eliminating gut bacterial beta-glucuronidase enzyme activity

  2024cites this paper
• Glucuronidation of orally administered drugs and the value of nanocarriers in strategies for its overcome.

  2024cites this paper
• Cryo-EM Structure of Recombinantly Expressed hUGDH Unveils a Hidden, Alternative Allosteric Inhibitor

  2024cites this paper
• The Role of UDP-Glycosyltransferases in Xenobiotic Metabolism

  2024influential citation
• Similarities in Structure and Function of UDP-Glycosyltransferase Homologs from Human and Plants

  2024cites this paper
• Redox remodeling of central metabolism as a driving force for cellular protection, proliferation, differentiation, and dysfunction

  2024cites this paper
• Investigation of in vitro biotransformation of tris (1-chloro-2-propyl) phosphate and confirmation in human urine

  2024cites this paper
• Genome-wide analyses of neonatal jaundice reveal a marked departure from adult bilirubin metabolism

  2024cites this paper
• A review on phytochemical constituents, analytical data, and pharmacological properties of the genus Plumeria

  2024cites this paper
• Drug-drug interactions of plant alkaloids derived from herbal medicines on the phase II UGT enzymes: an introductory review

  2024cites this paper
• Kinetic Characterization of Estradiol Glucuronidation by Liver Microsomes and Expressed UGT Enzymes: The Effects of Organic Solvents

  2024cites this paper
• Phenol (bio)isosteres in drug design and development

  2024cites this paper
• Knocking Out of UDP-Glycosyltransferase Gene UGT2B10 via CRISPR/Cas9 in Helicoverpa armigera Reveals Its Function in Detoxification of Insecticides.

  2024cites this paper
• Role of Personalized Medicine in Clinical Practice: An Overview of Current and Future Perspectives

  2024cites this paper
• Identification of UDP-glucuronosyltransferase (UGT) isoforms involved in the metabolism of Chlorophenols (CPs).

  2024cites this paper
• Gene networks and metabolomic screening analysis revealed specific pathways of amino acid and acylcarnitine profile alterations in blood plasma of patients with Parkinson’s disease and vascular parkinsonism

  2024cites this paper
• The expanding role of gene-based prescribing for phase II drug-metabolizing enzymes

  2023cites this paper
• A Review of Drug Abuse, Misuse, and Related Laboratory Challenges.

  2023cites this paper
• Glucuronidation Pathways of 5- and 7-Hydroxypropranolol: Determination of Glucuronide Structures and Enzyme Selectivity

  2023cites this paper
• Identification of Molecular Targets of Bile Acids Acting on Colorectal Cancer and Their Correlation with Immunity

  2023cites this paper
• Establishment of UGT1A1-knockout human iPS-derived hepatic organoids for UGT1A1-specific kinetics and toxicity evaluation

  2023cites this paper
• Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality

  2023cites this paper
• Exploring the role of detoxification genes in the resistance of Bursaphelenchus xylophilus to different exogenous nematicidal substances using transcriptomic analyses.

  2023cites this paper
• Placing steroid hormones within the human ABCC3 transporter reveals a compatible amphiphilic substrate‐binding pocket

  2023cites this paper
• Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis

  2023cites this paper
• Heterodimerization of Human UDP-Glucuronosyltransferase 1A9 and UDP-Glucuronosyltransferase 2B7 Alters Their Glucuronidation Activities

  2023cites this paper
• The Prevalence of Several Treatments in Preventing the Back Conversion of Acyl Glucuronide Metabolites in Abbreviated New Drug Applications

  2023cites this paper
• Oral arsenic administration to humanizedUDP-glucuronosyltransferase1 neonatal mice induces UGT1A1 through a dependence on Nrf2 and PXR

  2023cites this paper
• Utility of ToxTracker in animal alternative testing strategy for fragrance materials

  2023cites this paper
• Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine

  2023cites this paper
• Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group

  2023cites this paper
• The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism

  2023cites this paper
• Distilling functional variations for human UGT2B4 upstream region based on selection signals and implications for phenotypes of Neanderthal and Denisovan

  2023cites this paper
• Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.

  2023cites this paper
• Curcumin-loaded alginate hydrogels for cancer therapy and wound healing applications: A review.

  2023cites this paper
• Investigating the Contribution of Major Drug-Metabolising Enzymes to Possum-Specific Fertility Control

  2023cites this paper
• Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of Pain

  2023cites this paper
• Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions

  2023cites this paper
• Clinical trials and promising preclinical applications of CRISPR/Cas gene editing.

  2022cites this paper
• Effects of Pro-Inflammatory Cytokines on Hepatic Metabolism in Primary Human Hepatocytes

  2022cites this paper
• Genome-wide analysis of neonatal jaundice reveals a marked departure from adult bilirubin metabolism

  2022cites this paper
• Characterization of Clofazimine Metabolism in Human Liver Microsomal Incubation In Vitro

  2022cites this paper
• Machine learning and structure-based modeling for the prediction of UDP-glucuronosyltransferase inhibition

  2022influential citation
• Estimation of fraction of drug metabolism by a single UDP‐glucuronosyl transferase enzyme using relative expression factor

  2022cites this paper
• Inhibition of CYP2C8 by Acyl Glucuronides of Gemfibrozil and Clopidogrel: Pharmacological Significance, Progress and Challenges

  2022cites this paper
• Co-exposure health risk of benzo[a]pyrene with aromatic VOCs: Monoaromatic hydrocarbons inhibit the glucuronidation of benzo[a]pyrene.

  2022cites this paper
• Predicting Regioselectivity of AO, CYP, FMO, and UGT Metabolism Using Quantum Mechanical Simulations and Machine Learning.

  2022cites this paper
• Metabolism-involved drug interactions with traditional Chinese medicines in cardiovascular diseases

  2022cites this paper
• Effects of common genetic variants of human uridine diphosphate glucuronosyltransferase subfamilies on irinotecan glucuronidation

  2022cites this paper
• Deepening the Whole Transcriptomics of Bovine Liver Cells Exposed to AFB1: A Spotlight on Toll-like Receptor 2

  2022cites this paper
• Integrate thermostabilized fusion protein apocytochrome b 562 RIL and N-glycosylation mutations: A novel approach to heterologous expression of human UDP-glucuronosyltransferase (UGT) 2B7

  2022cites this paper
• The search for genetic dark matter and lessons learned from the journey.

  2022cites this paper
• “Domain Directional Optimization” Strategy for the Development of Ugt1a1-Activated Fluorescent Probe and the Application in Living Systems

  2022cites this paper
• Evolution of Green Blood in New Guinea Lizards: Phylogenomics, Biogeography, and Comparative Genomics

  2022cites this paper
• Complete Reaction Phenotyping of Propranolol and 4-Hydroxypropranolol with the 19 Enzymes of the Human UGT1 and UGT2 Families

  2022cites this paper
• Contribution of genetic factors to high rates of neonatal hyperbilirubinaemia on the Thailand-Myanmar border

  2022cites this paper
• Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment.

  2022cites this paper
• Effect of the genetic mutant G71R in uridine diphosphate-glucuronosyltransferase 1A1 on the conjugation of bilirubin

  2022cites this paper
• Transformation Products of Emerging Pollutants Explored Using Non-Target Screening: Perspective in the Transformation Pathway and Toxicity Mechanism—A Review

  2022cites this paper
• Biotoxicity Evaluation of a Cationic Star Polymer on a Predatory Ladybird and Cooperative Pest Control by Polymer-Delivered Pesticides and Ladybird.

  2022cites this paper
• Dependence of blood biochemical parameters on various genotypes of the UGT1A1 gene associated with gilbert's syndrome.

  2022cites this paper
• Maternal Nutrient Restriction Disrupts Gene Expression and Metabolites Associated with Urea Cycle, Steroid Synthesis, Glucose Homeostasis, and Glucuronidation in Fetal Calf Liver

  2022cites this paper
• Computer-Aided Drug Design (CADD) to De-Orphanize Marine Molecules: Finding Potential Therapeutic Agents for Neurodegenerative and Cardiovascular Diseases

  2022cites this paper